These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28267627)

  • 1. Stop codon mutagenesis for homogenous expression of human papillomavirus L1 protein in Escherichia coli.
    Wang D; Fan F; Li Z; Liu X; Song S; Wei S; He M; Lin Y; Li Z; Wei M; Yu H; Gu Y; Li S; Xia N
    Protein Expr Purif; 2017 May; 133():110-120. PubMed ID: 28267627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro.
    Wei M; Wang D; Li Z; Song S; Kong X; Mo X; Yang Y; He M; Li Z; Huang B; Lin Z; Pan H; Zheng Q; Yu H; Gu Y; Zhang J; Li S; Xia N
    Emerg Microbes Infect; 2018 Sep; 7(1):160. PubMed ID: 30254257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Level Production of Human Papillomavirus (HPV) Type 16 L1 in Escherichia coli.
    Bang HB; Lee YH; Lee YJ; Jeong KJ
    J Microbiol Biotechnol; 2016 Feb; 26(2):356-63. PubMed ID: 26608168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic.
    Chen Y; Liu Y; Zhang G; Wang A; Dong Z; Qi Y; Wang J; Zhao B; Li N; Jiang M
    Virus Res; 2016 Jul; 220():97-103. PubMed ID: 27107614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and Expression of L1 Protein Human Papillomavirus Type 31 Isolated from Iranian Patients in Escherichia coli.
    Hajmohammadi S; Rassi H
    Monoclon Antib Immunodiagn Immunother; 2016 Aug; 35(4):181-5. PubMed ID: 27244269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression, purification and immunogenicity analysis of HPV type 18 virus-like particles from Escherichia coli].
    Xie M; Li S; Shen W; Li Z; Zhuang Y; Mo X; Gu Y; Wu T; Zhang J; Xia N
    Sheng Wu Gong Cheng Xue Bao; 2009 Jul; 25(7):1082-7. PubMed ID: 19835152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prokaryotic expression of HPV 16 L1 gene and identification of its immune activity].
    Hao DF; Ma ZH; Wang YP; Rexidan ; Zhang FC
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):428-31. PubMed ID: 15989783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and purification of human papillomavirus type 33 L1 virus-like particles from Spodoptera frugiperda 9 cells using two-step column chromatography.
    Baek JO; Seo JW; Kim IH; Kim CH
    Protein Expr Purif; 2011 Feb; 75(2):211-7. PubMed ID: 20716445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing the expression levels of papillomavirus major capsid protein in Escherichia coli by N-terminal deletion.
    Ma Z; Chen B; Zhang F; Yu M; Liu T; Liu L
    Protein Expr Purif; 2007 Nov; 56(1):72-9. PubMed ID: 17616400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an RNA aptamer against HPV-16 L1 virus-like particles.
    Leija-Montoya AG; Benítez-Hess ML; Toscano-Garibay JD; Alvarez-Salas LM
    Nucleic Acid Ther; 2014 Oct; 24(5):344-55. PubMed ID: 25111024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viable adenovirus vaccine prototypes: high-level production of a papillomavirus capsid antigen from the major late transcriptional unit.
    Berg M; Difatta J; Hoiczyk E; Schlegel R; Ketner G
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4590-5. PubMed ID: 15767581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized production strategy of the major capsid protein HPV 16L1 non-assembly variant in E. coli.
    Roos N; Breiner B; Preuss L; Lilie H; Hipp K; Herrmann H; Horn T; Biener R; Iftner T; Simon C
    Protein Expr Purif; 2020 Nov; 175():105690. PubMed ID: 32681956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
    Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
    Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with Human Papillomavirus 16 L1+E2 Chimeric Capsomers Elicits Cellular Immune Response and Antitumor Activity in a Mouse Model.
    López-Toledo G; Schädlich L; Alonso-Castro ÁJ; Monroy-García A; García-Rocha R; Guido MC; Gissmann L; García-Carrancá A
    Viral Immunol; 2016 Jun; 29(5):276-87. PubMed ID: 27058179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing the secondary structure of human papillomavirus type 16 L1 mRNA enhances L1 protein expression in Saccharomyces cerevisiae.
    Kim HJ; Lee SJ; Kim HJ
    J Biotechnol; 2010 Oct; 150(1):31-6. PubMed ID: 20696192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells.
    Mossadegh N; Gissmann L; Müller M; Zentgraf H; Alonso A; Tomakidi P
    Virology; 2004 Aug; 326(1):57-66. PubMed ID: 15262495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VLP production in Leishmania tarentolae: A novel expression system for purification and assembly of HPV16 L1.
    Bolhassani A; Shirbaghaee Z; Agi E; Davoudi N
    Protein Expr Purif; 2015 Dec; 116():7-11. PubMed ID: 26304732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Codon optimization of the human papillomavirus type 58 L1 gene enhances the expression of soluble L1 protein in Saccharomyces cerevisiae.
    Kim HJ; Kwag HL; Kim HJ
    Biotechnol Lett; 2013 Mar; 35(3):413-21. PubMed ID: 23183918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression, purification and immunogenicity of human papillomavirus type 11 virus-like particles from Escherichia coli].
    Yan C; Li S; Wang J; Wei M; Huang B; Zhuang Y; Li Z; Pan H; Zhang J; Xia N
    Wei Sheng Wu Xue Bao; 2009 Nov; 49(11):1527-33. PubMed ID: 20112683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine.
    Hassan SW; Waheed MT; Müller M; Clarke JL; Shinwari ZK; Lössl AG
    Hum Vaccin Immunother; 2014; 10(10):2975-82. PubMed ID: 25483463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.